We are live on ! Find out more
BSTG

Biostage, Inc. Common Stock
BSTG

Delisted

BSTG was delisted on the 5th of October, 2017.

Back to rankings

0 hedge funds and large institutions have $0 invested in Biostage, Inc. Common Stock in 2017 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 25 → 0 (-25)

100% less capital invested

Capital invested by funds: $773K → $0 (-$773K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 25

Holders
–
Holders Change
-25
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
25
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$285K
2
BlackRock
BlackRock
New York
-$188K
3
PAM
Panagora Asset Management
Massachusetts
-$65K
4
Renaissance Technologies
Renaissance Technologies
New York
-$65K
5
State of New Jersey Common Pension Fund D
State of New Jersey Common Pension Fund D
New Jersey
-$32K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
– -$285K -922,509 Closed
BlackRock
2
BlackRock
New York
– -$188K -609,129 Closed
PAM
3
Panagora Asset Management
Massachusetts
– -$65K -211,820 Closed
Renaissance Technologies
4
Renaissance Technologies
New York
– -$65K -211,700 Closed
State of New Jersey Common Pension Fund D
5
State of New Jersey Common Pension Fund D
New Jersey
– -$32K -105,000 Closed
VF
6
Virtu Financial
New York
– -$22K -70,685 Closed
California Public Employees Retirement System
7
California Public Employees Retirement System
California
– -$20K -64,800 Closed
Bank of New York Mellon
8
Bank of New York Mellon
New York
– -$19K -58,036 Closed
Northern Trust
9
Northern Trust
Illinois
– -$14K -46,453 Closed
GWI
10
Grace & White Inc
New York
– -$9K -30,000 Closed
Geode Capital Management
11
Geode Capital Management
Massachusetts
– -$8K -26,101 Closed
TSS
12
Two Sigma Securities
New York
– -$8K -25,915 Closed
WIC
13
Woodmont Investment Counsel
Tennessee
– -$7K -22,500 Closed
GAG
14
GM Advisory Group
New York
– -$5K -15,525 Closed
Commonwealth Equity Services
15
Commonwealth Equity Services
Massachusetts
– -$5K -14,547 Closed
BII
16
Bainco International Investors
Massachusetts
– -$4K -14,200 Closed
Susquehanna International Group
17
Susquehanna International Group
Pennsylvania
– -$4K -13,387 Closed
Goldman Sachs
18
Goldman Sachs
New York
– -$4K -12,250 Closed
Morgan Stanley
19
Morgan Stanley
New York
– -$4K -10,772 Closed
UBS Group
20
UBS Group
Switzerland
– -$3K -9,565 Closed
Citigroup
21
Citigroup
New York
– -$2K -6,000 Closed

BSTG Hedge Fund Activity: Q4 2017 in Review

0 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Biostage, Inc. Common Stock (BSTG) for Q4 2017, worth a combined $0 — down 100% from $773K a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of BSTG and 0 opened new positions — a net loss of 25 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Vanguard Group, exiting entirely with an estimated $285K sold.

  • 0 institutional investors held Biostage, Inc. Common Stock (BSTG) as of Q4 2017, down from 25 in Q3 2017.
  • Funds reported $0 of Biostage, Inc. Common Stock stock for Q4 2017, down 100% quarter-over-quarter.
  • 0 funds opened new Biostage, Inc. Common Stock positions in Q4 2017 and 25 closed out, a net change of -25 holders.
  • The largest Biostage, Inc. Common Stock seller in Q4 2017 was Vanguard Group, an estimated $285K sold.

Based on aggregated 13F filings for Q4 2017.